aim
consis
statement
improv
qualiti
transpar
report
season
avian
pandem
influenza
seroepidemiolog
studi
order
valid
generaliz
result
better
assess
statement
also
aim
improv
design
conduct
influenza
seroepidemiolog
studi
propos
report
standard
investig
consid
design
studi
consis
develop
number
protocol
guid
design
implement
seroepidemiolog
studi
protocol
avail
http
consisetghnorgarticlesavailableconsiseinfluenzaprotocol
valuabl
resourc
consult
addit
statement
tabl
compon
statement
use
checklist
help
guid
key
inform
includ
result
publish
seroepidemiolog
studi
also
serv
guid
item
need
consid
studi
design
implement
report
guidelin
statement
intend
requir
framework
must
follow
content
format
also
design
instrument
assess
studi
qualiti
instrument
refer
review
identifi
search
pubm
conduct
may
updat
may
use
term
seroepidemiolog
studi
mesh
influenza
human
mesh
titl
abstract
articl
publish
english
review
inform
relev
studi
includ
review
individu
seroepidemiolog
studi
referenc
demonstr
princip
relev
report
standard
standard
compris
checklist
item
address
addit
strobe
item
suggest
refin
strobe
item
specif
applic
seroepidemiolog
studi
exist
strobe
item
cover
issu
full
specif
addit
refin
requir
seroepidemiolog
studi
strobe
item
given
tabl
correspond
item
facilit
clear
identif
studi
quantit
measur
antibodi
concentr
member
defin
popul
order
make
infer
exposur
popul
emerg
respiratori
virus
transmiss
sever
one
term
seroepidemiolog
seroepidemiolog
seropreval
seroincid
use
titl
andor
abstract
studi
mesh
term
seroepidemiolog
studi
use
keyword
tabl
valid
infer
viru
infect
risk
base
serolog
depend
upon
knowledg
kinet
antibodi
respons
follow
viru
infect
perform
antibodi
detect
assay
introduct
provid
background
inform
justifi
choic
antibodi
detect
assay
threshold
specif
antibodi
titer
chang
antibodi
titer
may
indic
prior
recent
infect
depend
design
seroepidemiolog
studi
provid
data
varieti
measur
frequenc
outcom
studi
popul
exampl
seroepidemiolog
studi
provid
estim
point
preval
differ
titer
antibodi
use
marker
prior
infect
vaccin
may
indic
current
level
protect
infect
antigen
similar
virus
protect
threshold
correl
protect
establish
word
seropreval
antibodi
titer
prefer
infect
antibodi
titer
dynam
initi
rise
gener
declin
variabl
period
infect
therefor
differ
assumpt
underli
infer
prior
infect
antibodi
concentr
serolog
test
pair
serum
specimen
provid
estim
cumul
incid
viru
infect
incid
proport
serial
prospect
longitudin
cohort
studi
use
estim
cumul
incid
viru
serolog
also
use
studi
popul
specif
set
household
healthcar
set
confin
set
militari
unit
childelderli
care
center
prison
estim
risk
secondari
viru
infect
estim
seropreval
antibodi
specif
popul
specif
measur
occurr
estim
eg
point
seropreval
cumul
incid
secondari
infect
risk
describ
introduct
number
differ
seroepidemiolog
studi
design
use
estim
variou
measur
viru
infect
risk
differ
design
differ
strength
weak
depend
object
investig
tabl
method
section
begin
describ
studi
design
studi
popul
sampl
procedur
eg
random
conveni
sourc
serum
plasma
analyz
eg
frozen
store
vs
recent
collect
test
rational
choos
studi
design
generaliz
beyond
studi
popul
infer
probabl
prior
recent
viru
infect
base
titer
antibodi
singl
serum
sampl
chang
titer
antibodi
sequenti
serum
sampl
base
upon
assumpt
kinet
antibodi
titer
follow
viru
infect
order
reader
assess
test
valid
assum
relationship
import
detail
provid
actual
like
period
exposur
circul
viru
strain
infect
risk
relat
time
point
serum
sampl
taken
exampl
overli
short
day
overli
long
month
interv
exposur
serum
sampl
increas
probabl
uninterpret
result
antibodi
titer
may
yet
reach
maximum
titer
may
decay
seropreval
seroconvers
titer
detect
threshold
set
defin
infect
retrospect
studi
close
contact
confirm
influenza
case
eg
household
contact
confirm
case
tabl
household
transmiss
studi
monitor
seroconvers
order
estim
incid
secondari
infect
addit
strobe
criteria
report
studi
subject
detail
method
criteria
identifi
index
case
patient
report
probabl
onward
transmiss
may
vari
accord
characterist
index
case
patient
tabl
thu
comparison
result
differ
viru
transmiss
studi
requir
inform
exampl
subject
clinic
ill
sever
enough
seek
medic
care
preexist
comorbid
condit
immunosuppress
poorli
develop
immun
system
eg
young
infant
may
infecti
mild
case
patient
detect
activ
case
contact
similarli
viru
load
clinic
specimen
therefor
infect
may
differ
among
subject
infect
detect
viru
cultur
molecular
diagnost
techniqu
rapid
antigen
detect
poc
diagnost
test
addit
durat
intens
rout
exposur
index
case
patient
ill
influenc
infecti
index
case
patient
close
contact
studi
viru
infect
transmiss
risk
household
close
set
outbreak
investig
definit
set
studi
eg
household
defin
describ
order
permit
comparison
similar
studi
result
seroepidemiolog
studi
among
human
antibodi
novel
avian
influenza
virus
aiv
sometim
challeng
interpret
difficult
distinguish
detect
low
titer
antibodi
detect
low
titer
antibodi
seroepidemiolog
survey
novel
aiv
ideal
compar
seropreval
expos
popul
seropreval
popul
like
expos
anim
reservoir
sick
human
case
patient
report
effort
valid
assay
virolog
confirm
case
age
import
determin
serolog
respons
viru
infect
therefor
critic
median
rang
age
particip
overal
subgroup
studi
subject
control
popul
control
group
similar
median
age
age
rang
studi
group
report
influenza
antibodi
may
present
result
immun
therefor
essenti
vaccin
exist
detail
provid
vaccin
use
studi
popul
vaccin
administ
relat
time
sampl
collect
investig
method
use
identifi
record
vaccin
histori
well
statist
method
use
control
potenti
effect
immun
data
avail
vaccin
studi
popul
gener
popul
studi
particip
chosen
state
clearli
along
anecdot
inform
presenc
absenc
vaccin
period
studi
pathogen
share
similar
antigen
epitop
antibodi
assay
may
detect
one
pathogen
exampl
antibodi
influenza
viru
detect
serum
sampl
collect
prior
emerg
pandem
viru
antibodi
typic
found
older
peopl
expos
earlier
influenza
virus
particularli
therefor
known
potenti
immunolog
effort
detect
control
also
report
influenza
viru
infect
result
wide
rang
clinic
outcom
asymptomat
infect
rapidli
progress
fatal
ill
differ
definit
clinic
ill
differ
method
ascertain
presenc
absenc
clinic
ill
variabl
sensit
specif
detect
ill
definit
method
use
identifi
clinic
outcom
describ
order
permit
generaliz
studi
result
prefer
studi
popul
close
possibl
gener
popul
studi
howev
alway
feasibl
exampl
mani
serolog
studi
detect
antibodi
viru
infect
conduct
use
residu
sera
blood
hospit
may
repres
broader
popul
locat
potenti
introduc
select
bia
studi
address
discuss
method
use
infer
cumul
incid
infect
among
popul
base
result
studi
sampl
exampl
weight
standard
report
suffici
detail
permit
reproduc
addit
confid
result
conclus
seroepidemiolog
studi
depend
among
thing
whether
plan
studi
sampl
size
suffici
provid
estim
preval
incid
infect
suffici
precis
assess
whether
plan
sampl
size
adequ
assum
baselin
preval
given
antibodi
titer
baselin
cumul
incid
given
chang
antibodi
titer
report
differ
plan
actual
sampl
size
also
report
differ
explain
seroepidemiolog
studi
particularli
import
full
detail
condit
assay
method
detect
antibodi
report
includ
upper
lower
limit
antibodi
dilut
rang
assay
detect
addit
variabl
condit
assay
describ
minimum
detect
level
assay
limit
defin
calcul
report
handl
analysi
sampl
result
borderlin
minimum
detect
level
result
minimum
detect
level
assay
consist
antibodi
titer
anywher
zero
limit
detect
titer
analyz
interpret
affect
result
especi
constitut
larg
proport
result
common
convent
accept
consid
result
limit
detect
serial
step
limit
start
antibodi
dilut
valu
report
five
purpos
data
analysi
rather
zero
detect
similarli
antibodi
titer
threshold
defin
seroposit
result
critic
import
yet
studi
fairli
arbitrari
threshold
design
high
specif
diagnost
purpos
case
clinic
ill
may
provid
reliabl
estim
viru
infect
rate
popul
level
specif
optim
expens
therefor
criterion
defin
posit
result
either
indic
prior
infect
infer
protect
justif
use
criterion
particular
studi
set
must
report
immunolog
correl
protect
influenza
viru
infect
ill
difficult
establish
relationship
antibodi
titer
protect
binari
complet
protect
titer
threshold
complet
unprotect
threshold
therefor
result
use
make
infer
proport
popul
popul
subgroup
protect
import
justifi
refer
known
correl
antibodi
titer
measur
specif
assay
protect
infect
ill
studi
seropreval
estim
proport
specimen
antibodi
titer
specif
threshold
confid
interv
typic
obtain
use
binomi
formula
normal
approxim
binomi
number
addit
assumpt
met
includ
seropreval
epidem
low
almost
infect
individu
rise
convalesc
antibodi
titer
chosen
threshold
seropreval
provid
approxim
estim
cumul
incid
note
seropreval
proport
rate
studi
pair
sera
cumul
incid
viru
infect
estim
proport
person
rise
antibodi
titer
tradit
fourfold
greater
studi
confid
interv
typic
estim
use
binomi
formula
normal
approxim
binomi
implicitli
assum
person
experi
one
viru
infect
period
consid
noteworthi
point
also
cumul
incid
viru
infect
sometim
refer
attack
rate
although
proport
infect
may
asymptomat
therefor
attack
quantiti
measur
proport
rate
term
cumul
incid
infect
therefor
prefer
attack
rate
context
serolog
studi
either
case
method
use
account
probabl
seroposit
seroconvers
infect
method
use
account
decay
antibodi
titer
time
report
increas
transpar
cumul
incid
infect
estim
often
help
report
unadjust
estim
distribut
antibodi
titer
age
group
studi
particularli
complex
design
term
time
serolog
measur
improv
estim
seropreval
certain
point
time
cumul
incid
infect
specifi
time
period
may
obtain
fit
observ
data
mechanist
model
transmiss
account
data
although
serum
sampl
commonli
use
serolog
studi
conveni
sampl
may
enabl
access
plasma
use
anticoagul
separ
plasma
shown
reduc
antibodi
titer
influenza
thu
defin
sampl
type
anticoagul
use
necessari
storag
condit
durat
subsequ
treatment
sampl
eg
temperatur
number
freezethaw
cycl
import
report
known
repeat
freezethaw
cycl
may
also
reduc
antibodi
titer
possibl
standard
serolog
assay
eg
hemagglutin
inhibit
hai
assay
detect
hai
antibodi
microneutr
mn
assay
detect
neutral
antibodi
influenza
virus
specimen
prepar
assay
protocol
provid
either
referenc
publish
protocol
chang
specifi
detail
methodolog
novel
serolog
assay
paramet
may
induc
variabl
antibodi
detect
assay
use
state
necessari
report
detail
antigen
use
includ
viru
name
subtyp
strain
lineag
clade
well
prepar
type
eg
live
viru
inactiv
viru
recombin
protein
antigen
antigen
equival
specif
viru
strain
studi
popul
expos
enabl
comparison
laboratori
also
aid
develop
specif
serolog
assay
laboratori
detect
paramet
red
blood
cell
speci
concentr
percent
vv
elisa
substrat
start
end
dilut
etc
number
replic
perform
control
well
biosafeti
requir
report
definit
method
endpoint
titer
calcul
state
interpret
data
reliant
appropri
descript
limit
serolog
assay
reproduc
assay
perform
addit
serolog
assay
confirm
calibr
result
appropri
includ
specif
recommend
virus
recommend
use
confirmatori
serolog
assay
upon
detect
singl
serum
posit
mn
assay
confirmatori
assay
use
criteria
posit
also
need
describ
detail
inclus
avail
intern
facilit
compar
serolog
data
inclus
actual
titer
obtain
intern
standard
indic
whether
data
report
raw
valu
intern
valu
therefor
describ
unadjust
estim
titer
age
group
report
result
studi
sampl
standard
gener
target
popul
method
standard
report
differ
seroepidemiolog
studi
design
differ
strength
weak
review
summar
consis
group
tabl
limit
strength
studi
design
report
cover
discuss
tabl
may
use
refer
discuss
limit
strength
interpret
seroepidemiolog
studi
critic
depend
specif
assay
addit
strobe
item
specif
attent
given
interpret
result
context
known
potenti
rosesi
direct
compar
influenza
seroepidemiolog
studi
current
limit
lack
standard
across
statement
aim
improv
qualiti
transpar
report
studi
studi
better
assess
understood
outlin
methodolog
design
studi
popul
epidemiolog
data
collect
specimen
collect
handl
method
laboratori
method
justif
criteria
seroposit
report
result
limit
bias
includ
report
find
seroepidemiolog
studi
aim
like
standard
report
eg
consort
strobe
develop
accept
standard
report
influenza
seroepidemiolog
studi
novel
influenza
virus
emerg
rapid
robust
evalu
implic
seroepidemiolog
studi
critic
order
fulli
assess
popul
health
risk
need
mitig
measur
without
inform
report
abil
interpret
seroepidemiolog
studi
novel
influenza
virus
limit
first
version
checklist
hope
refin
use
feedback
approach
use
consis
influenza
seroepidemiolog
studi
item
outlin
statement
like
applic
adapt
emerg
respiratori
virus
middl
east
respiratori
syndrom
coronaviru
howev
simplic
statement
describ
focus
influenza
virus
reason
entitl
statement
allow
extens
acronym
rose
pathogen
